CSL 0.14% $309.72 csl limited

News: CSL CSL Commences Manufacturing Of University Of Oxford/Astrazeneca Vaccine Candidate In...

  1. 191,980 Posts.
    lightbulb Created with Sketch. 2809

    Nov 7 (Reuters) - CSL Limited:

    • CSL COMMENCES MANUFACTURING OF UNIVERSITY OF OXFORD/ASTRAZENECA VACCINE CANDIDATE IN MELBOURNE
    • CSL - WILL COMMENCE MANUFACTURING OF OXFORD/ASTRAZENECA VACCINE AZD1222 COVID-19 VACCINE CANDIDATE AT ITS FACILITY IN BROADMEADOWS, ON MONDAY, NOV 9
    • CSL - MANUFACTURING PROCESS OF OXFORD/ASTRAZENECA VACCINE CANDIDATE WILL START WITH THE THAW OF VIALS CONTAINING VACCINE CELLS
    • CSL - HAS SEPARATE CONTRACTS WITH ASTRAZENECA, THE AUSTRALIAN GOVERNMENT TO MANUFACTURE ABOUT 30 MILLION DOSES OF THE AZD1222 VACCINE CANDIDATE
    • CSL - FIRST DOSES PLANNED FOR RELEASE IN THE FIRST HALF OF 2021, PENDING THE OUTCOME OF CLINICAL TRIALS AND REGULATORY

    Source : https://bit.ly/2IfVttt

    (([email protected];))

 
watchlist Created with Sketch. Add CSL (ASX) to my watchlist
(20min delay)
Last
$309.72
Change
0.430(0.14%)
Mkt cap ! $149.6B
Open High Low Value Volume
$310.10 $311.54 $308.61 $295.6M 953.7K

Buyers (Bids)

No. Vol. Price($)
8 14819 $309.72
 

Sellers (Offers)

Price($) Vol. No.
$310.00 36 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.